AMANDA HOOD NELSON: Open Payments
NPI 1467935882 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$904 in 52 payments from 14 companies in 2025. Trend: 2023 $461 · 2024 $415 · 2025 $904
Food & beverage: $904
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $368 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $178 |
| Otsuka America Pharmaceutical, Inc. | 4 | $76 |
| Axsome Therapeutics, Inc. | 2 | $48 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 2 | $34 |
| Novo Nordisk Inc | 1 | $26 |
| ViiV Healthcare Company | 1 | $23 |
| Corium, LLC | 2 | $22 |
| Seqirus USA Inc | 1 | $19 |
Products named: CAPLYTA, QULIPTA, VRAYLAR, UBRELVY, REXULTI, AIRSUPRA, SPRAVATO, Ozempic.
Industry payments across UT — which companies pay providers there.
